神经调节用于怀孕期间的头痛管理
Liza Smirnoff1, Michelle Bravo2, Tayina Hyppolite2
1Department of Neurology - Headache Division, University of Miami Health, University of Miami School of Medicine, 1120 NW 14th Street, 13th Floor, Miami, FL, 33136, USA. lxs1704@med.miami.edu.
Current pain and headache reports
|January 8, 2025
概括
非侵入性神经调节器械为孕妇患者管理初级头痛疾病提供了安全,有效和非药物选择. 有限但有希望的证据表明,这些治疗方法可能会改善孕妇的护理.
科学领域:
- 神经学 神经学
- 医疗器械 医疗器械
- 产科 产科 产科 产科 产科
背景情况:
- 由于制药安全问题,怀孕期间主发性头痛疾病的管理具有挑战性.
- 孕妇头痛患者的治疗选择有限.
研究的目的:
- 探索孕妇非侵入性神经调节器械的安全性和有效性.
- 评估怀孕期间初级头痛疾病的替代治疗方法.
主要方法:
- 对FDA批准的非侵入性神经调节器械进行审查.
- 评估有关怀孕期间安全性和耐受性的现有证据.
主要成果:
- 有六种FDA批准的设备可供使用:远程电神经调节 (REN),非侵入性阴道神经刺激 (nVNS),外部三角神经刺激 (eTNS),单脉冲横磁刺激 (sTMS) 和外部并发性头和三角神经刺激 (eCOT-NS).
- 神经调节器设备通常是安全的,有效的,并对主要头痛疾病耐受良好.
- 在怀孕期间使用的证据有限,但表明潜在的治疗益处.
结论:
- 非侵入性神经调节器设备代表了孕妇患有初级头痛疾病的孕妇可行的非药物治疗选择.
- 这些设备可以作为替代或辅助疗法,以改善怀孕期间头痛的管理.
- 需要进一步的研究,以在孕妇人群中建立可靠的安全性和疗效数据.
相关概念视频
Skeletal Muscle Relaxants: Therapeutic Uses
463
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
463
Analgesia and Pain Management
490
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
490
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
147
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
147


